SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers(Erasmus MC), Corine H. GeurtsvanKessel(Erasmus University Rotterdam)
Cited by 591
Related Papers
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells
|The Journal of Experimental Medicine|2008|465
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
|Science Immunology|2022|438
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
|Journal of Antimicrobial Chemotherapy|2023|23
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study
|Clinical Infectious Diseases|2024|15
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study
|International Journal of Infectious Diseases|2024|8